[{"id":"4d9062bd-6ef9-440b-a47b-45996bf8d8fe","acronym":"","url":"https://clinicaltrials.gov/study/NCT02655952","created_at":"2021-04-07T13:53:08.789Z","updated_at":"2024-07-02T16:37:04.344Z","phase":"Phase 1","brief_title":"Dose Escalating Study of Foxy-5 in Breast-, Colon- or Prostate Cancer Patients","source_id_and_acronym":"NCT02655952","lead_sponsor":"WntResearch AB","biomarkers":" WNT5A","pipe":"","alterations":" ","tags":["WNT5A"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Foxy-5"],"overall_status":"Completed","enrollment":" Enrollment 17","initiation":"Initiation: 04/01/2016","start_date":" 04/01/2016","primary_txt":" Primary completion: 10/01/2017","primary_completion_date":" 10/01/2017","study_txt":" Completion: 10/01/2017","study_completion_date":" 10/01/2017","last_update_posted":"2018-12-28"}]